Press "esc" to clear
Go to Advanced Search

Showing results

110 of 63

Article ID: 697145

Loyola Medicine, Palos Health First in Illinois To Offer MRI-Guided Radiation Therapy

Loyola University Health System

The Loyola Center for Cancer Care & Research at Palos Health South Campus in Orland Park is the first center in Illinois – and only the fifth in the country – to offer a groundbreaking MRI-guided radiation therapy that targets tumors with millimeter precision.

Released:
9-Jul-2018 11:05 AM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
fatty-liver-disease-Intermountain.jpg

Article ID: 696967

Economic Burden of Fatty Liver Disease in U.S. is $32 Billion Annually, New Study Finds

Intermountain Medical Center

Nonalcoholic fatty liver disease, or NAFLD, which affects roughly 100 million Americans, costs the United States healthcare system $32 billion annually, according to a first-of-its-kind study by Intermountain Healthcare researchers on the economic impact of the disease.

Released:
3-Jul-2018 4:05 AM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment

Article ID: 696924

Mount Sinai Researchers Highlight New Mechanisms and Therapeutic Strategies for Non-Alcoholic Fatty Liver Disease in Nature Medicine

Mount Sinai Health System

A new review published online on Monday, July 2, in Nature Medicine highlights cutting-edge research associated with non-alcoholic fatty liver disease (NAFLD) and its more advanced, and worrisome, form, non-alcoholic steatohepatitis (NASH).

Released:
2-Jul-2018 11:05 AM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment

Article ID: 696228

BIDMC Researchers Develop Decision-Making Tool to Benefit Patients with HCV

Beth Israel Deaconess Medical Center

BIDMC researchers led a retrospective analysis of four randomized clinical trials focused on the effects of DAA therapies in patients with HCV-associated liver failure and developed a new means of predicting improvement in liver function in response to DAA treatment.

Released:
18-Jun-2018 10:05 AM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
michigan-med-l-virtual-visit-01.jpg

Article ID: 696011

Video consultations increase liver disease survival

Michigan Medicine - University of Michigan

For patients who live in rural areas, driving to see a specialist in a large city or at a university hospital can be challenging, if not impossible. But providing their physicians with virtual access to specialists can be lifesaving to liver disease patients.

Released:
13-Jun-2018 8:00 AM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
tumor-section.jpg

Article ID: 695885

UT Southwestern investigators identify missing link in kidney cancer prognosis

UT Southwestern Medical Center

Normal cells located next to kidney cancer cells provide new clues about prognosis and survival rates, researchers from UT Southwestern Medical Center’s Kidney Cancer Program report.

Released:
8-Jun-2018 5:05 PM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
loomba_rohit_NASH.jpg

Article ID: 695810

Rohit Loomba, MD, @UCSDHealth liver expert on NASH and the First International NASH Day

University of California San Diego Health

Released:
7-Jun-2018 4:05 PM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
  • Embargo expired:
    7-Jun-2018 1:05 AM EDT

Article ID: 695556

Half of Hepatitis C Patients with Private Insurance Denied Life-Saving Drugs

Perelman School of Medicine at the University of Pennsylvania

The number of insurance denials for life-saving hepatitis C drugs among patients with both private and public insurers remains high across the United States. Private insurers had the highest denial rates, with 52.4 percent of patients denied coverage, while Medicaid denied 34.5 percent of patients and Medicare denied 14.7 percent.

Released:
4-Jun-2018 2:05 PM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
Witztum_aorta_OxPL.png

Article ID: 695707

Antibody Blocks Inflammation, Protects Mice from Hardened Arteries and Liver Disease

University of California San Diego Health

Researchers at University of California San Diego School of Medicine discovered that they can block inflammation in mice with a naturally occurring antibody that binds oxidized phospholipids (OxPL), molecules on cell surfaces that get modified by inflammation. Even while on a high-fat diet, the antibody protected the mice from arterial plaque formation, hardening of the arteries and liver disease, and prolonged their lives.

Released:
6-Jun-2018 1:05 PM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
FUSFNortham_51.JPG

Article ID: 695700

Virginia Governor Northam Visits Foundation to Discuss Global Impact of State’s Investment in Focused Ultrasound

Focused Ultrasound Foundation

On Tuesday, June 5, Virginia Governor Ralph Northam visited the Focused Ultrasound Foundation and met with the Foundation’s staff as well as with members of the Foundation’s Board and Council, and donors. Virginia House of Delegates Leader David Toscano, representatives from the University of Virginia, and members of the local media were also in attendance.

Released:
6-Jun-2018 1:05 PM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment

Showing results

110 of 63





Chat now!